Coinfection
IAS 2013: HIV/HCV Coinfected Children in Europe Have Poor Hepatitis C Treatment Outcomes
- Details
- Category: HIV/HCV Coinfection
- Published on Wednesday, 24 July 2013 00:00
- Written by Liz Highleyman
HIV/HCV coinfection was uncommon among children and adolescents in a large European cohort, but within this group hepatitis C treatment generally occurred late and rarely led to sustained response, researchers reported at the 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013) this month in Kuala Lumpur.
IAS 2013: HIV/HCV Coinfected People Do Well on HCV Triple Therapy Despite Contraindications
- Details
- Category: HIV/HCV Coinfection
- Published on Friday, 19 July 2013 00:00
- Written by Liz Highleyman
Nearly three-quarters of HIV/HCV coinfected patients in the French HEPAVIH cohort achieved end-of-treatment virological response to hepatitis C treatment with telaprevir plus pegylated interferon/ribavirin, even though one-third had potential contraindications to this type of therapy, according to a report at the 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013) this month in Kuala Lumpur.
CROI 2013: Adding Telaprevir Increases Acute Hepatitis C Cure Rate for HIV+ Men
- Details
- Category: HIV/Hepatitis Coinfection
- Published on Tuesday, 12 March 2013 00:00
- Written by Liz Highleyman
Adding telaprevir (Incivek) to pegylated interferon and ribavirin shortens the duration of therapy and improves the likelihood of a cure for HIV positive men with acute sexually transmitted hepatitis C virus (HCV), according to study findings presented at the 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013) last week in Atlanta.
Marijuana Does Not Promote Liver Disease Progression in HIV/HCV Coinfected People
- Details
- Category: HIV/HCV Coinfection
- Published on Tuesday, 16 July 2013 00:00
- Written by Liz Highleyman
Smoking cannabis was not associated with liver fibrosis progression in a study of nearly 700 people with HIV and hepatitis C coinfection, according to a study described in the June 28, 2013, advance edition of Clinical Infectious Diseases.
CROI 2013: Adding Telaprevir Ups Acute Hepatitis C Cure Rate for HIV+ Men [VIDEO]
- Details
- Category: HIV/Hepatitis Coinfection
- Published on Friday, 08 March 2013 00:00
- Written by Gregory Fowler
Adding telaprevir (Incivek) to pegylated interferon/ribavirin for treating HIV positive men with acute sexually transmitted hepatitis C considerably shortens the duration of therapy and improves the likelihood of a cure, according to study findings presented this week at the 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013) in Atlanta.
Hepatitis E Can Cause Rapid Liver Cirrhosis in People with HIV Who Have Low CD4 Cell Counts
- Details
- Category: HIV/Hepatitis Coinfection
- Published on Thursday, 30 May 2013 00:00
- Written by Michael Carter
Infection with hepatitis E virus (HEV) can cause rapid liver fibrosis in people with HIV who have low CD4 cell counts, case reports published in the April 10, 2013, online edition of Clinical Infectious Diseases show. Spanish investigators reported 2 instances of HEV infection in gay men with HIV who had severe immunosuppression. Treatment with ribavirin monotherapy led to normalization of liver function and temporary suppression of HEV replication.
Tenofovir plus Emtricitabine or Lamivudine Does Not Always Suppress Hepatitis B in HIV/HBV Coinfected
- Details
- Category: HIV/HBV Coinfection
- Published on Thursday, 28 February 2013 00:00
- Written by Liz Highleyman
HIV/HBV coinfected people with high hepatitis B virus (HBV) levels and those who are HBeAg positive are at greater risk of not achieving HBV suppression after a year on tenofovir plus emtricitabine or lamivudine, but most did so eventually, researchers reported in the February 21, 2013, advance online edition of AIDS.
EASL 2013: HIV/HCV Coinfected at Risk for Decompensation, May Need Prompt Treatment
- Details
- Category: HIV/HCV Coinfection
- Published on Wednesday, 22 May 2013 00:00
- Written by Liz Highleyman
HIV positive people with hepatitis C coinfection may experience liver decompensation with advanced fibrosis, even before they progress to cirrhosis, and may therefore benefit from earlier antiviral treatment, researchers reported at the EASL International Liver Congress (EASL 2013) last month in Amsterdam.
AASLD 2012: Final Study Results Show Telaprevir Is Safe and Effective for HIV/HCV Coinfected Patients
- Details
- Category: HIV/HCV Coinfection
- Published on Monday, 12 November 2012 00:00
- Written by Liz Highleyman
HIV/HCV coinfected people treated with telaprevir (Incivek) triple therapy are significantly more likely to achieve sustained virological response, or a cure, than people treated with pegylated interferon/ribavirin alone, according to final results from Study 110 presented at the American Association for the Study of Liver Diseases Liver Meeting (AASLD 2012) this week in Boston.
Web Design and Development by